Zdrowie i gospodarka · 16/04/2018
FDA Issues Guidance on Highly Concentrated Caffeine in Dietary Supplements
The FDA is releasing a guidance document to help manufacturers, marketers, and distributors of dietary supplements containing pure or highly concentrated caffeine understand the regulations and reduce the risk of adulteration under the FD&C Act.
Source: Federal Register — Food and Drug AdministrationOpen original release →